Why the study?
Do statins reduce coronary heart disease risk in elderly patients?
Population
Elderly patients, including those aged 70-82 years, up to age 80 years for secondary prevention, and over 75…
Design
Review
Authors
Loading...
Supports statin consideration for elderly secondary prevention; leaves open dedicated RCTs for primary prevention beyond age 80.
Do statins reduce coronary heart disease risk in elderly patients?
Statin therapy provides significant cardiovascular benefits in elderly patients, particularly for secondary prevention and in those with diabetes, with benefits outweighing the low risk of serious side effects.
Walker et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: